APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiotherapy

Radiotherapy (Radiation Therapy) is a method of treating cancer. It is divided into External Beam Radiotherapy, also known as teleradiation therapy and Internal Beam Radiotherapy, also known as brachytherapy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiotherapy (Radiation Therapy) is a method of treating cancer. It is divided into External Beam Radiotherapy, also known as teleradiation therapy and Internal Beam Radiotherapy, also known as brachytherapy. The principle is to use high-energy ionizing radiation (such as X-rays, gamma rays, high-energy electrons or heavy particles) produced by Medical Electron Linear Accelerator or radioactive nuclei to control or destroy malignant cells. Radiation therapy can cure some cancers that are only present in specific parts of the body, and can also be used as adjuvant therapy to prevent the recurrence of tumors after surgery to remove the primary malignant tumor (for example, to treat early-stage breast cancer). Ionizing radiation can damage the DNA of cancer tissue, causing its cells to die. In order to leave normal tissues (such as skin or organs, through which radiation must pass to treat tumors) unaffected, the radiation beam will illuminate the cancerous tissue from several specific angles. Tumors produce a much greater absorbed dose than surrounding healthy tissue. In addition to the tumor itself, the radiation field may also include draining lymph nodes if they are clinically or radiologically associated with malignancy or are considered to be at risk for subclinical malignant spread. Either way, the cells are killed by destroying the genetic material (DNA) of malignant cells. Cancer cells whose DNA is damaged and cannot be repaired will stop dividing or die. When damaged cells die, they are broken down and eliminated by the body. Radiation therapy does not kill cancer cells immediately; the level of DNA damage that causes cancer cell death requires days or weeks of treatment.

Radiotherapy equipment is an important treatment tool in current tumor treatment, including Medical Electron Linear Accelerator, Gamma Knife, Cyberknife, TomoTherapy, proton and heavy ion equipment, etc., among which the global The most commonly used one is the Medical Electron Linear Accelerator. Medical Electron Linear Accelerator is usually used clinically to define and plan the treatment target area based on CT images, and to give the target area a certain dose of uniform irradiation. In radiotherapy, target volume delineation, measurement prescription design, and radiotherapy plan design can all directly affect the effect of radiotherapy. However, because delineation and design work rely on technicians and radiotherapy doctors, there are many uncertainties. The positioning error is one of the important factors affecting the accuracy of radiotherapy. In addition, there are many factors that cause positioning and imaging differences during the entire radiotherapy process for patients, making it difficult for the entire radiotherapy effect to fully achieve the intended goal.

Proton and heavy particle therapy are another modality. Proton therapy, also known as "proton knife", uses neutral uncharged particles (such as neutrons) or charged particles (such as protons) to enter the human body and release energy to kill tumor cells. Currently, protons and Carbon ions. The entire treatment process can provide powerful irradiation to tumor lesions while avoiding irradiation of normal tissues to maximize the curative effect. Proton radiotherapy is currently the most cutting-edge cancer treatment technology. In the world of cancer treatment, heavy ions are another word for carbon ions (C6+). It is said that the dose concentration of heavy ions is better than that of protons, and the killing effect on cancer cells is 2-3 times that of protons. This effect can reduce the number of fractions and shorten the treatment cycle. Heavy ion therapy is also expected to be effective in treating cancers that are resistant to conventional X-ray radiation therapy, such as sarcomas and adenocarcinomas, locally advanced cancers, and deep-seated cancers. Broadly speaking, a heavy ion beam includes any beam of particles heavier than electrons. In heavy ion radiation therapy in Japan, the term "heavy ion beam" refers to a beam of nuclei (heavy ions) of any atom heavier than helium (He) or with an atomic number greater than helium. In Japan, carbon ion beams have been used for heavy ion beam therapy for nearly 20 years. Therefore, "heavy ion beam" currently refers to "carbon ion beam".

The research object may be an ingredient, device, preparation or care service. These supply stages have different specifications and measurement units; an ingredient identity or device name does not establish a clinical outcome.

What turns activity into demand

Qualified use at the specified treatment or instrument boundary creates purchases through protocol, utilisation and replacement. A product, clinical service and complete care episode measure different supplied objects.

The commercial boundary

For Radiotherapy, distinguish the supplied product from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.

Which conditions determine usable radiotherapy performance?

Radiotherapy (Radiation Therapy) is a method of treating cancer. It is divided into External Beam Radiotherapy, also known as teleradiation therapy and Internal Beam Radiotherapy, also known as brachytherapy. Confirm the specified composition or device function, intended use and supplied unit. Separate ingredients, finished preparations, equipment and treatment activity before comparing quantities or revenue; use the report scope rather than inferring efficacy from an illustration.

Selected research

Market Outlook & Growth Opportunities

Global Radiotherapy Market Outlook and Growth Opportunities 2026

21 December 2025196 pages

Choose your research edition.

Industry ResearchRadiotherapy Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiotherapy Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Radiotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiotherapy Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiotherapy Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Radiotherapy (Radiation Therapy) is a method of treating cancer. It is divided into External Beam Radiotherapy, also known as teleradiation therapy and Internal Beam Radiotherapy, also known as brachytherapy. The principle is to use high-energy ionizing radiation (such as X-rays, gamma rays, high-energy electrons or heavy particles) produced by Medical Electron Linear Accelerator or radioactive nuclei to control or destroy malignant cells. Radiation therapy can cure some cancers that are only present in specific parts of the body, and can also be used as adjuvant therapy to prevent the recurrence of tumors after surgery to remove the primary malignant tumor (for example, to treat early-stage breast cancer). Ionizing radiation can damage the DNA of cancer tissue, causing its cells to die. In order to leave normal tissues (such as skin or organs, through which radiation must pass to treat tumors) unaffected, the radiation beam will illuminate the cancerous tissue from several specific angles. Tumors produce a much greater absorbed dose than surrounding healthy tissue. In addition to the tumor itself, the radiation field may also include draining lymph nodes if they are clinically or radiologically associated with malignancy or are considered to be at risk for subclinical malignant spread. Either way, the cells are killed by destroying the genetic material (DNA) of malignant cells. Cancer cells whose DNA is damaged and cannot be repaired will stop dividing or die. When damaged cells die, they are broken down and eliminated by the body. Radiation therapy does not kill cancer cells immediately; the level of DNA damage that causes cancer cell death requires days or weeks of treatment.

Radiotherapy equipment is an important treatment tool in current tumor treatment, including Medical Electron Linear Accelerator, Gamma Knife, Cyberknife, TomoTherapy, proton and heavy ion equipment, etc., among which the global The most commonly used one is the Medical Electron Linear Accelerator. Medical Electron Linear Accelerator is usually used clinically to define and plan the treatment target area based on CT images, and to give the target area a certain dose of uniform irradiation. In radiotherapy, target volume delineation, measurement prescription design, and radiotherapy plan design can all directly affect the effect of radiotherapy. However, because delineation and design work rely on technicians and radiotherapy doctors, there are many uncertainties. The positioning error is one of the important factors affecting the accuracy of radiotherapy. In addition, there are many factors that cause positioning and imaging differences during the entire radiotherapy process for patients, making it difficult for the entire radiotherapy effect to fully achieve the intended goal.

Proton and heavy particle therapy are another modality. Proton therapy, also known as "proton knife", uses neutral uncharged particles (such as neutrons) or charged particles (such as protons) to enter the human body and release energy to kill tumor cells. Currently, protons and Carbon ions. The entire treatment process can provide powerful irradiation to tumor lesions while avoiding irradiation of normal tissues to maximize the curative effect. Proton radiotherapy is currently the most cutting-edge cancer treatment technology. In the world of cancer treatment, heavy ions are another word for carbon ions (C6+). It is said that the dose concentration of heavy ions is better than that of protons, and the killing effect on cancer cells is 2-3 times that of protons. This effect can reduce the number of fractions and shorten the treatment cycle. Heavy ion therapy is also expected to be effective in treating cancers that are resistant to conventional X-ray radiation therapy, such as sarcomas and adenocarcinomas, locally advanced cancers, and deep-seated cancers. Broadly speaking, a heavy ion beam includes any beam of particles heavier than electrons. In heavy ion radiation therapy in Japan, the term "heavy ion beam" refers to a beam of nuclei (heavy ions) of any atom heavier than helium (He) or with an atomic number greater than helium. In Japan, carbon ion beams have been used for heavy ion beam therapy for nearly 20 years. Therefore, "heavy ion beam" currently refers to "carbon ion beam".

Read the full market overview

The global Radiotherapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Radiotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Radiotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Asia Pacific market for Radiotherapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Radiotherapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Radiotherapy market include Varian Medical Systems (Siemens Healthineers), Elekta, Hitachi, IBA(Ion Beam Applications S.A), Accuray, Mevion Medical Systems, Shanghai United Imaging Healthcare, Shinva Medical Instrument and Toshiba, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Radiotherapy market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Radiotherapy and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radiotherapy sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radiotherapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Radiotherapy Segment by Company

Varian Medical Systems (Siemens Healthineers)

Elekta

Hitachi

IBA(Ion Beam Applications S.A)

Accuray

Mevion Medical Systems

Shanghai United Imaging Healthcare

Shinva Medical Instrument

Toshiba

Neusoft Medical Systems

Chengdu Linike Medical

Sumitomo Heavy Industries

Jiangsu Haiming Medical Equipment

SinoPower Accelerator

Radiotherapy Segment by Type

External Beam Radiotherapy

Internal Beam Radiotherapy

Radiotherapy Segment by Application

Lung Cancer

Breast Cancer

Rectal Cancer

Prostate Cancer

Stomach Cancer

Liver Cancer

Cervical Cancer

Lung Cancer

Head and Neck Cancer

Other

Radiotherapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Radiotherapy status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Radiotherapy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Radiotherapy significant trends, drivers, influence factors in global and regions.

6. To analyze Radiotherapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiotherapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Radiotherapy market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radiotherapy industry.

Chapter 3: Detailed analysis of Radiotherapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Radiotherapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Radiotherapy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Radiotherapy Industry Trends Table 2. Radiotherapy Industry Drivers Table 3. Radiotherapy Industry Opportunities and Challenges Table 4. Radiotherapy Industry Restraints Table 5. Global Radiotherapy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Radiotherapy Revenue Share by Company (2021-2026) Table 7. Global Radiotherapy Sales Volume by Company (Units) & (2021-2026) Table 8. Global Radiotherapy Sales Volume Share by Company (2021-2026) Table 9. Global Radiotherapy Average Price ($M/Unit) of Company (2021-2026) Table 10. Global Radiotherapy Company Ranking, (2024-2026) & (USD Million) Table 11. Global Radiotherapy Key Company Manufacturing Base & Headquarters Table 12. Global Radiotherapy Company, Product Type & Application Table 13. Global Radiotherapy Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Radiotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of External Beam Radiotherapy Table 18. Significant Companies of Internal Beam Radiotherapy Table 19. Global Radiotherapy Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Radiotherapy Sales Volume by Type (2021-2026) & (Units) Table 21. Global Radiotherapy Sales Volume by Type (2027-2032) & (Units) Table 22. Global Radiotherapy Sales Volume Share by Type (2021-2026) Table 23. Global Radiotherapy Sales Volume Share by Type (2027-2032) Table 24. Global Radiotherapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Radiotherapy Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Radiotherapy Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Radiotherapy Sales Value Share by Type (2021-2026) Table 28. Global Radiotherapy Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Lung Cancer Table 30. Significant Companies of Breast Cancer Table 31. Significant Companies of Rectal Cancer Table 32. Significant Companies of Prostate Cancer Table 33. Significant Companies of Stomach Cancer Table 34. Significant Companies of Liver Cancer Table 35. Significant Companies of Cervical Cancer Table 36. Significant Companies of Lung Cancer Table 37. Significant Companies of Head and Neck Cancer Table 38. Significant Companies of Other Table 39. Global Radiotherapy Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 40. Global Radiotherapy Sales Volume by Application (2021-2026) & (Units) Table 41. Global Radiotherapy Sales Volume by Application (2027-2032) & (Units) Table 42. Global Radiotherapy Sales Volume Share by Application (2021-2026) Table 43. Global Radiotherapy Sales Volume Share by Application (2027-2032) Table 44. Global Radiotherapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Radiotherapy Sales Value by Application (2021-2026) & (US$ Million) Table 46. Global Radiotherapy Sales Value by Application (2027-2032) & (US$ Million) Table 47. Global Radiotherapy Sales Value Share by Application (2021-2026) Table 48. Global Radiotherapy Sales Value Share by Application (2027-2032) Table 49. Global Radiotherapy Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 50. Global Radiotherapy Sales by Region (2021-2026) & (Units) Table 51. Global Radiotherapy Sales Market Share by Region (2021-2026) Table 52. Global Radiotherapy Sales by Region (2027-2032) & (Units) Table 53. Global Radiotherapy Sales Market Share by Region (2027-2032) Table 54. Global Radiotherapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Radiotherapy Sales Value by Region (2021-2026) & (US$ Million) Table 56. Global Radiotherapy Sales Value Share by Region (2021-2026) Table 57. Global Radiotherapy Sales Value by Region (2027-2032) & (US$ Million) Table 58. Global Radiotherapy Sales Value Share by Region (2027-2032) Table 59. Global Radiotherapy Market Average Price ($M/Unit) by Region (2021-2026) Table 60. Global Radiotherapy Market Average Price ($M/Unit) by Region (2027-2032) Table 61. Global Radiotherapy Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 62. Global Radiotherapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Radiotherapy Sales by Country (2021-2026) & (Units) Table 64. Global Radiotherapy Sales Market Share by Country (2021-2026) Table 65. Global Radiotherapy Sales by Country (2027-2032) & (Units) Table 66. Global Radiotherapy Sales Market Share by Country (2027-2032) Table 67. Global Radiotherapy Sales Value by Country (2021-2026) & (US$ Million) Table 68. Global Radiotherapy Sales Value Market Share by Country (2021-2026) Table 69. Global Radiotherapy Sales Value by Country (2027-2032) & (US$ Million) Table 70. Global Radiotherapy Sales Value Market Share by Country (2027-2032) Table 71. Varian Medical Systems (Siemens Healthineers) Company Information Table 72. Varian Medical Systems (Siemens Healthineers) Business Overview Table 73. Varian Medical Systems (Siemens Healthineers) Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 74. Varian Medical Systems (Siemens Healthineers) Radiotherapy Product Portfolio Table 75. Varian Medical Systems (Siemens Healthineers) Recent Development Table 76. Elekta Company Information Table 77. Elekta Business Overview Table 78. Elekta Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 79. Elekta Radiotherapy Product Portfolio Table 80. Elekta Recent Development Table 81. Hitachi Company Information Table 82. Hitachi Business Overview Table 83. Hitachi Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 84. Hitachi Radiotherapy Product Portfolio Table 85. Hitachi Recent Development Table 86. IBA(Ion Beam Applications S.A) Company Information Table 87. IBA(Ion Beam Applications S.A) Business Overview Table 88. IBA(Ion Beam Applications S.A) Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 89. IBA(Ion Beam Applications S.A) Radiotherapy Product Portfolio Table 90. IBA(Ion Beam Applications S.A) Recent Development Table 91. Accuray Company Information Table 92. Accuray Business Overview Table 93. Accuray Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 94. Accuray Radiotherapy Product Portfolio Table 95. Accuray Recent Development Table 96. Mevion Medical Systems Company Information Table 97. Mevion Medical Systems Business Overview Table 98. Mevion Medical Systems Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 99. Mevion Medical Systems Radiotherapy Product Portfolio Table 100. Mevion Medical Systems Recent Development Table 101. Shanghai United Imaging Healthcare Company Information Table 102. Shanghai United Imaging Healthcare Business Overview Table 103. Shanghai United Imaging Healthcare Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 104. Shanghai United Imaging Healthcare Radiotherapy Product Portfolio Table 105. Shanghai United Imaging Healthcare Recent Development Table 106. Shinva Medical Instrument Company Information Table 107. Shinva Medical Instrument Business Overview Table 108. Shinva Medical Instrument Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 109. Shinva Medical Instrument Radiotherapy Product Portfolio Table 110. Shinva Medical Instrument Recent Development Table 111. Toshiba Company Information Table 112. Toshiba Business Overview Table 113. Toshiba Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 114. Toshiba Radiotherapy Product Portfolio Table 115. Toshiba Recent Development Table 116. Neusoft Medical Systems Company Information Table 117. Neusoft Medical Systems Business Overview Table 118. Neusoft Medical Systems Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 119. Neusoft Medical Systems Radiotherapy Product Portfolio Table 120. Neusoft Medical Systems Recent Development Table 121. Chengdu Linike Medical Company Information Table 122. Chengdu Linike Medical Business Overview Table 123. Chengdu Linike Medical Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 124. Chengdu Linike Medical Radiotherapy Product Portfolio Table 125. Chengdu Linike Medical Recent Development Table 126. Sumitomo Heavy Industries Company Information Table 127. Sumitomo Heavy Industries Business Overview Table 128. Sumitomo Heavy Industries Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 129. Sumitomo Heavy Industries Radiotherapy Product Portfolio Table 130. Sumitomo Heavy Industries Recent Development Table 131. Jiangsu Haiming Medical Equipment Company Information Table 132. Jiangsu Haiming Medical Equipment Business Overview Table 133. Jiangsu Haiming Medical Equipment Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 134. Jiangsu Haiming Medical Equipment Radiotherapy Product Portfolio Table 135. Jiangsu Haiming Medical Equipment Recent Development Table 136. SinoPower Accelerator Company Information Table 137. SinoPower Accelerator Business Overview Table 138. SinoPower Accelerator Radiotherapy Sales (Units), Value (US$ Million), Price ($M/Unit) and Gross Margin (2021-2026) Table 139. SinoPower Accelerator Radiotherapy Product Portfolio Table 140. SinoPower Accelerator Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Radiotherapy Distributors List Table 144. Radiotherapy Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Radiotherapy Product Image Figure 2. Global Radiotherapy Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiotherapy Sales Value (2021-2032) & (US$ Million) Figure 4. Global Radiotherapy Sales (2021-2032) & (Units) Figure 5. Global Radiotherapy Sales Average Price ($M/Unit) & (2021-2032) Figure 6. Global Radiotherapy Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. External Beam Radiotherapy Image Figure 10. Internal Beam Radiotherapy Image Figure 11. Global Radiotherapy Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Radiotherapy Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Radiotherapy Sales Volume Share by Type (2021-2032) Figure 14. Global Radiotherapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Radiotherapy Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Radiotherapy Sales Value Share by Type (2021-2032) Figure 17. Lung Cancer Image Figure 18. Breast Cancer Image Figure 19. Rectal Cancer Image Figure 20. Prostate Cancer Image Figure 21. Stomach Cancer Image Figure 22. Liver Cancer Image Figure 23. Cervical Cancer Image Figure 24. Lung Cancer Image Figure 25. Head and Neck Cancer Image Figure 26. Other Image Figure 27. Global Radiotherapy Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 28. Global Radiotherapy Sales Volume Share 2021 VS 2025 VS 2032 Figure 29. Global Radiotherapy Sales Volume Share by Application (2021-2032) Figure 30. Global Radiotherapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Radiotherapy Sales Value Share 2021 VS 2025 VS 2032 Figure 32. Global Radiotherapy Sales Value Share by Application (2021-2032) Figure 33. Global Radiotherapy Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 34. Global Radiotherapy Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Radiotherapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Radiotherapy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Radiotherapy Sales Value (2021-2032) & (US$ Million) Figure 38. North America Radiotherapy Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Europe Radiotherapy Sales Value (2021-2032) & (US$ Million) Figure 40. Europe Radiotherapy Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Asia-Pacific Radiotherapy Sales Value (2021-2032) & (US$ Million) Figure 42. Asia-Pacific Radiotherapy Sales Value Share by Country (%), 2025 VS 2032 Figure 43. South America Radiotherapy Sales Value (2021-2032) & (US$ Million) Figure 44. South America Radiotherapy Sales Value Share by Country (%), 2025 VS 2032 Figure 45. Middle East & Africa Radiotherapy Sales Value (2021-2032) & (US$ Million) Figure 46. Middle East & Africa Radiotherapy Sales Value Share by Country (%), 2025 VS 2032 Figure 47. USA Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. USA Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. USA Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Canada Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Canada Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Canada Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Mexico Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Mexico Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Mexico Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Germany Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Germany Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Germany Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. France Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. France Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. France Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. U.K. Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. U.K. Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. U.K. Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Italy Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Italy Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Italy Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Spain Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Spain Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Spain Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Russia Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Russia Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Russia Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Netherlands Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Netherlands Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Netherlands Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Nordic Countries Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Nordic Countries Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Nordic Countries Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. China Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. China Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. China Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Japan Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Japan Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Japan Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. South Korea Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. South Korea Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. South Korea Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. India Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. India Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. India Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Australia Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Australia Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Australia Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Southeast Asia Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Southeast Asia Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Southeast Asia Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Brazil Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Brazil Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Brazil Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Argentina Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Argentina Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Argentina Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Chile Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Chile Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Chile Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Colombia Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Colombia Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Colombia Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Peru Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Peru Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Peru Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Saudi Arabia Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Saudi Arabia Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Israel Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Israel Arabia Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Israel Arabia Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. UAE Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. UAE Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. UAE Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Turkey Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Turkey Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Turkey Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Iran Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Iran Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Iran Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Egypt Radiotherapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 129. Egypt Radiotherapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 130. Egypt Radiotherapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 131. Radiotherapy Value Chain Figure 132. Manufacturing Cost Structure Figure 133. Radiotherapy Sales Mode & Process Figure 134. Direct Comparison with Distribution Share Figure 135. Distributors Profiles Figure 136. Years Considered Figure 137. Research Process Figure 138. Key Executives Interviewed

Scope & coverage.

Types
  • External Beam Radiotherapy
  • Internal Beam Radiotherapy
Applications
  • Lung Cancer
  • Breast Cancer
  • Rectal Cancer
  • Prostate Cancer
  • Stomach Cancer
  • Liver Cancer
  • Cervical Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Other
Companies covered
  • Varian Medical Systems (Siemens Healthineers)
  • Elekta
  • Hitachi
  • IBA(Ion Beam Applications S.A)
  • Accuray
  • Mevion Medical Systems
  • Shanghai United Imaging Healthcare
  • Shinva Medical Instrument
  • Toshiba
  • Neusoft Medical Systems
  • Chengdu Linike Medical
  • Sumitomo Heavy Industries
  • Jiangsu Haiming Medical Equipment
  • SinoPower Accelerator

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radiotherapy Sales Value (2021-2032)
  4. 1.2.2 Global Radiotherapy Sales Volume (2021-2032)
  5. 1.2.3 Global Radiotherapy Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Radiotherapy Market Dynamics
  1. 2.1 Radiotherapy Industry Trends
  2. 2.2 Radiotherapy Industry Drivers
  3. 2.3 Radiotherapy Industry Opportunities and Challenges
  4. 2.4 Radiotherapy Industry Restraints
3 Radiotherapy Market by Company
  1. 3.1 Global Radiotherapy Company Revenue Ranking in 2025
  2. 3.2 Global Radiotherapy Revenue by Company (2021-2026)
  3. 3.3 Global Radiotherapy Sales Volume by Company (2021-2026)
  4. 3.4 Global Radiotherapy Average Price by Company (2021-2026)
  5. 3.5 Global Radiotherapy Company Ranking (2024-2026)
  6. 3.6 Global Radiotherapy Company Manufacturing Base and Headquarters
  7. 3.7 Global Radiotherapy Company Product Type and Application
  8. 3.8 Global Radiotherapy Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Radiotherapy Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Radiotherapy Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Radiotherapy Market by Type
  1. 4.1 Radiotherapy Type Introduction
  2. 4.1.1 External Beam Radiotherapy
  3. 4.1.2 Internal Beam Radiotherapy
  4. 4.2 Global Radiotherapy Sales Volume by Type
  5. 4.2.1 Global Radiotherapy Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Radiotherapy Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Radiotherapy Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Radiotherapy Sales Value by Type
  9. 4.3.1 Global Radiotherapy Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Radiotherapy Sales Value by Type (2021-2032)
  11. 4.3.3 Global Radiotherapy Sales Value Share by Type (2021-2032)
5 Radiotherapy Market by Application
  1. 5.1 Radiotherapy Application Introduction
  2. 5.1.1 Lung Cancer
  3. 5.1.2 Breast Cancer
  4. 5.1.3 Rectal Cancer
  5. 5.1.4 Prostate Cancer
  6. 5.1.5 Stomach Cancer
  7. 5.1.6 Liver Cancer
  8. 5.1.7 Cervical Cancer
  9. 5.1.8 Lung Cancer
  10. 5.1.9 Head and Neck Cancer
  11. 5.1.10 Other
  12. 5.2 Global Radiotherapy Sales Volume by Application
  13. 5.2.1 Global Radiotherapy Sales Volume by Application (2021 VS 2025 VS 2032)
  14. 5.2.2 Global Radiotherapy Sales Volume by Application (2021-2032)
  15. 5.2.3 Global Radiotherapy Sales Volume Share by Application (2021-2032)
  16. 5.3 Global Radiotherapy Sales Value by Application
  17. 5.3.1 Global Radiotherapy Sales Value by Application (2021 VS 2025 VS 2032)
  18. 5.3.2 Global Radiotherapy Sales Value by Application (2021-2032)
  19. 5.3.3 Global Radiotherapy Sales Value Share by Application (2021-2032)
6 Radiotherapy Regional Sales and Value Analysis
  1. 6.1 Global Radiotherapy Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radiotherapy Sales by Region (2021-2032)
  3. 6.2.1 Global Radiotherapy Sales by Region: 2021-2026
  4. 6.2.2 Global Radiotherapy Sales by Region (2027-2032)
  5. 6.3 Global Radiotherapy Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Radiotherapy Sales Value by Region (2021-2032)
  7. 6.4.1 Global Radiotherapy Sales Value by Region: 2021-2026
  8. 6.4.2 Global Radiotherapy Sales Value by Region (2027-2032)
  9. 6.5 Global Radiotherapy Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Radiotherapy Sales Value (2021-2032)
  12. 6.6.2 North America Radiotherapy Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Radiotherapy Sales Value (2021-2032)
  15. 6.7.2 Europe Radiotherapy Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Radiotherapy Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Radiotherapy Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Radiotherapy Sales Value (2021-2032)
  21. 6.9.2 South America Radiotherapy Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Radiotherapy Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Radiotherapy Sales Value Share by Country, 2025 VS 2032
7 Radiotherapy Country-level Sales and Value Analysis
  1. 7.1 Global Radiotherapy Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Radiotherapy Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Radiotherapy Sales by Country (2021-2032)
  4. 7.3.1 Global Radiotherapy Sales by Country (2021-2026)
  5. 7.3.2 Global Radiotherapy Sales by Country (2027-2032)
  6. 7.4 Global Radiotherapy Sales Value by Country (2021-2032)
  7. 7.4.1 Global Radiotherapy Sales Value by Country (2021-2026)
  8. 7.4.2 Global Radiotherapy Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Radiotherapy Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Radiotherapy Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Radiotherapy Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Radiotherapy Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Radiotherapy Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Radiotherapy Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Radiotherapy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Radiotherapy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Radiotherapy Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Radiotherapy Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Radiotherapy Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Radiotherapy Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Radiotherapy Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Radiotherapy Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Radiotherapy Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Radiotherapy Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Radiotherapy Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Radiotherapy Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Radiotherapy Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Radiotherapy Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Radiotherapy Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Radiotherapy Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Radiotherapy Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Radiotherapy Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Radiotherapy Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Radiotherapy Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Radiotherapy Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Radiotherapy Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Radiotherapy Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Radiotherapy Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Radiotherapy Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Radiotherapy Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Radiotherapy Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Radiotherapy Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Radiotherapy Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Radiotherapy Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Radiotherapy Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Radiotherapy Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Radiotherapy Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Radiotherapy Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Radiotherapy Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Radiotherapy Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Radiotherapy Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Radiotherapy Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Radiotherapy Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Radiotherapy Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Radiotherapy Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Radiotherapy Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Radiotherapy Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Radiotherapy Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Radiotherapy Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Radiotherapy Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Radiotherapy Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Radiotherapy Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Radiotherapy Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Radiotherapy Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Radiotherapy Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Radiotherapy Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Radiotherapy Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Radiotherapy Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Radiotherapy Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Radiotherapy Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Radiotherapy Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Radiotherapy Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Radiotherapy Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Radiotherapy Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Radiotherapy Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Radiotherapy Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Radiotherapy Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Radiotherapy Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Radiotherapy Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Radiotherapy Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Radiotherapy Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Radiotherapy Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Radiotherapy Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Radiotherapy Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Radiotherapy Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Radiotherapy Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Radiotherapy Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Radiotherapy Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Radiotherapy Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Radiotherapy Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Radiotherapy Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Radiotherapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Varian Medical Systems (Siemens Healthineers)
  2. 8.1.1 Varian Medical Systems (Siemens Healthineers) Company Information
  3. 8.1.2 Varian Medical Systems (Siemens Healthineers) Business Overview
  4. 8.1.3 Varian Medical Systems (Siemens Healthineers) Radiotherapy Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Varian Medical Systems (Siemens Healthineers) Radiotherapy Product Portfolio
  6. 8.1.5 Varian Medical Systems (Siemens Healthineers) Recent Developments
  7. 8.2 Elekta
  8. 8.2.1 Elekta Company Information
  9. 8.2.2 Elekta Business Overview
  10. 8.2.3 Elekta Radiotherapy Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Elekta Radiotherapy Product Portfolio
  12. 8.2.5 Elekta Recent Developments
  13. 8.3 Hitachi
  14. 8.3.1 Hitachi Company Information
  15. 8.3.2 Hitachi Business Overview
  16. 8.3.3 Hitachi Radiotherapy Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hitachi Radiotherapy Product Portfolio
  18. 8.3.5 Hitachi Recent Developments
  19. 8.4 IBA(Ion Beam Applications S.A)
  20. 8.4.1 IBA(Ion Beam Applications S.A) Company Information
  21. 8.4.2 IBA(Ion Beam Applications S.A) Business Overview
  22. 8.4.3 IBA(Ion Beam Applications S.A) Radiotherapy Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 IBA(Ion Beam Applications S.A) Radiotherapy Product Portfolio
  24. 8.4.5 IBA(Ion Beam Applications S.A) Recent Developments
  25. 8.5 Accuray
  26. 8.5.1 Accuray Company Information
  27. 8.5.2 Accuray Business Overview
  28. 8.5.3 Accuray Radiotherapy Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Accuray Radiotherapy Product Portfolio
  30. 8.5.5 Accuray Recent Developments
  31. 8.6 Mevion Medical Systems
  32. 8.6.1 Mevion Medical Systems Company Information
  33. 8.6.2 Mevion Medical Systems Business Overview
  34. 8.6.3 Mevion Medical Systems Radiotherapy Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mevion Medical Systems Radiotherapy Product Portfolio
  36. 8.6.5 Mevion Medical Systems Recent Developments
  37. 8.7 Shanghai United Imaging Healthcare
  38. 8.7.1 Shanghai United Imaging Healthcare Company Information
  39. 8.7.2 Shanghai United Imaging Healthcare Business Overview
  40. 8.7.3 Shanghai United Imaging Healthcare Radiotherapy Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai United Imaging Healthcare Radiotherapy Product Portfolio
  42. 8.7.5 Shanghai United Imaging Healthcare Recent Developments
  43. 8.8 Shinva Medical Instrument
  44. 8.8.1 Shinva Medical Instrument Company Information
  45. 8.8.2 Shinva Medical Instrument Business Overview
  46. 8.8.3 Shinva Medical Instrument Radiotherapy Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Shinva Medical Instrument Radiotherapy Product Portfolio
  48. 8.8.5 Shinva Medical Instrument Recent Developments
  49. 8.9 Toshiba
  50. 8.9.1 Toshiba Company Information
  51. 8.9.2 Toshiba Business Overview
  52. 8.9.3 Toshiba Radiotherapy Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Toshiba Radiotherapy Product Portfolio
  54. 8.9.5 Toshiba Recent Developments
  55. 8.10 Neusoft Medical Systems
  56. 8.10.1 Neusoft Medical Systems Company Information
  57. 8.10.2 Neusoft Medical Systems Business Overview
  58. 8.10.3 Neusoft Medical Systems Radiotherapy Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Neusoft Medical Systems Radiotherapy Product Portfolio
  60. 8.10.5 Neusoft Medical Systems Recent Developments
  61. 8.11 Chengdu Linike Medical
  62. 8.11.1 Chengdu Linike Medical Company Information
  63. 8.11.2 Chengdu Linike Medical Business Overview
  64. 8.11.3 Chengdu Linike Medical Radiotherapy Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Chengdu Linike Medical Radiotherapy Product Portfolio
  66. 8.11.5 Chengdu Linike Medical Recent Developments
  67. 8.12 Sumitomo Heavy Industries
  68. 8.12.1 Sumitomo Heavy Industries Company Information
  69. 8.12.2 Sumitomo Heavy Industries Business Overview
  70. 8.12.3 Sumitomo Heavy Industries Radiotherapy Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Sumitomo Heavy Industries Radiotherapy Product Portfolio
  72. 8.12.5 Sumitomo Heavy Industries Recent Developments
  73. 8.13 Jiangsu Haiming Medical Equipment
  74. 8.13.1 Jiangsu Haiming Medical Equipment Company Information
  75. 8.13.2 Jiangsu Haiming Medical Equipment Business Overview
  76. 8.13.3 Jiangsu Haiming Medical Equipment Radiotherapy Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Jiangsu Haiming Medical Equipment Radiotherapy Product Portfolio
  78. 8.13.5 Jiangsu Haiming Medical Equipment Recent Developments
  79. 8.14 SinoPower Accelerator
  80. 8.14.1 SinoPower Accelerator Company Information
  81. 8.14.2 SinoPower Accelerator Business Overview
  82. 8.14.3 SinoPower Accelerator Radiotherapy Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 SinoPower Accelerator Radiotherapy Product Portfolio
  84. 8.14.5 SinoPower Accelerator Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Radiotherapy Value Chain Analysis
  2. 9.1.1 Radiotherapy Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Radiotherapy Sales Mode & Process
  6. 9.2 Radiotherapy Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Radiotherapy Distributors
  9. 9.2.3 Radiotherapy Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst